We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,215
Reduced
3,564
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPKBW
10276
DELISTED
Silver Spike Acquisition Corp II Warrant
SPKBW
$147 ﹤0.01%
+4,900
New +$165
HERAW
10277
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$145 ﹤0.01%
4,819
+1,161
+32% +$47
VEEAW
10278
Veea Inc Warrant
VEEAW
$144 ﹤0.01%
7,200
+1,875
+35% +$70
IGTAR
10279
DELISTED
Inception Growth Acquisition Limited Rights
IGTAR
$144 ﹤0.01%
1,600
-2,699
-63% -$228
PTWOU
10280
DELISTED
Pono Capital Two, Inc. Unit
PTWOU
$143 ﹤0.01%
+14
New +$142
NXLIW
10281
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$140 ﹤0.01%
700
-2,470
-78% -$445
DRMAW icon
10282
Dermata Therapeutics Warrant
DRMAW
$14.1K
$138 ﹤0.01%
6,905
-2,195
-24% -$70
INVZW
10283
DELISTED
Innoviz Technologies Warrant
INVZW
$136 ﹤0.01%
+94
New +$171
APTX
10284
DELISTED
Aptinyx Inc. Common Stock
APTX
$134 ﹤0.01%
462
-26,933
-98% -$7.78K
ORIAW
10285
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$134 ﹤0.01%
896
-1
-0.1%
SBFMW
10286
Sunshine Biopharma Inc Warrant
SBFMW
$94.9K
$132 ﹤0.01%
400
-9,873
-96% -$4.72K
ORIA
10287
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$131 ﹤0.01%
13
TVGNW icon
10288
Tevogen Inc. Warrant
TVGNW
$854K
$130 ﹤0.01%
+17,377
New +$506
LCAHW
10289
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$130 ﹤0.01%
1,300
-1,158
-47% -$132
CEFA icon
10290
Global X S&P Catholic Values Developed ex-US ETF
CEFA
$56.5M
$129 ﹤0.01%
5
TTNP
10291
DELISTED
Titan Pharmaceuticals
TTNP
$129 ﹤0.01%
8
-551
-99% -$10.4K
NRSNW icon
10292
NeuroSense Therapeutics Warrant
NRSNW
$128 ﹤0.01%
798
-1,160
-59% -$293
DCRDW
10293
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$128 ﹤0.01%
228
-3,236
-93% -$1.89K
CYTHW
10294
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$127 ﹤0.01%
245
-792
-76% -$467
SFT
10295
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$127 ﹤0.01%
+85
New +$323
PSCX icon
10296
Pacer Swan SOS Conservative January ETF
PSCX
$46M
$126 ﹤0.01%
6
-1,703
-100% -$35.5K
BDRX
10297
Biodexa Pharmaceuticals
BDRX
$1.28M
0
ADERW
10298
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$123 ﹤0.01%
+492
New +$143
BYNOU
10299
DELISTED
byNordic Acquisition Corporation Units
BYNOU
$122 ﹤0.01%
+12
New +$120
GSJY icon
10300
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
$84.4M
$121 ﹤0.01%
4
-471
-99% -$13.8K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,215 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.